GSK’s Jemperli wins FDA approval for rectal cancer treatment
In
Investing.comBy Investing.com10/19/2026, 4:22:36 PM
EXECUTIVE SUMMARY
GSK’s Jemperli wins FDA approval for rectal cancer treatment....
Key Takeaways
- GSK’s Jemperli wins FDA approval for rectal cancer treatment.
Read Complete Original Article
Published originally on Investing.com
Related News
finance6 minutes ago
When should you dump your target-date funds?
Target-date funds aren’t necessarily built to handle many of the decisions retirees face.
finance14 minutes ago
Brazil budget shifts 1% of spending for election measures
Brazil budget shifts 1% of spending for election measures....
finance16 minutes ago
Cal-Maine Foods stock hits 52-week low at $61.86
Cal-Maine Foods stock hits 52-week low at $61.86....
finance19 minutes ago
Why is Varonis Systems stock slipping today?
Why is Varonis Systems stock slipping today?....
Multikhabar App
All Information In One Place
Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!